# US 2021/0275651 A1 · Plant virus or virus-like particle constructs

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0275651 A1
- Document ID: US20210275651A1
- Status: Published application
- Kind: A1
- Application number: 16/319,765
- Filed: 2017-07-21
- Published: 2021-09-09
- Earliest claimed: 2016-07-21
- Assignees: Case Western Reserve University
- Applicants: Case Western Reserve University
- Inventors: Nicole F. Steinmetz; Frank Alexander Veliz; Brylee David B. Tiu
- Web page: https://patentgrep.com/patent/US20210275651A1

## CPC

- A61K 47/6901: {Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors}
- A61K 39/0011: {Cancer antigens}
- A61K 39/385: Haptens or antigens, bound to carriers
- A61K 39/39: characterised by the immunostimulating additives, e.g. chemical adjuvants
- A61P 35/00: Antineoplastic agents
- A61K 2039/5258: {Virus-like particles}
- A61K 2039/55555: {Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers}
- A61K 2039/585: {wherein the target is cancer}
- A61K 2039/622: {non-covalent binding}
- A61K 2039/645: {Dendrimers; Multiple antigen peptides}
- B82Y 5/00: Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
- C12N 2770/18034: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

A nanoparticle construct includes a plurality of plant virus or virus-like particles electrostatically coupled to a plurality of nanoparticles having a different surface charge than the plant virus or virus-like particles. The nanoparticle construct upon delivery to a subject can provide a sustained release of the plant virus or virus-like particles and/or nanoparticles to a cell or tissue of the subject.

## Claims

### Claim at position 1

1-15. (canceled)

### Claim 16

A method of treating cancer in a subject in need thereof, the method comprising:
administering in situ to cancer cells of the subject a nanoparticle construct, the nanoparticle construct comprising:
a plurality of plant virus or virus-like particles and
a plurality of nanoparticles having a different surface charge than the plant virus or virus-like particles electrostatically coupled to the plant virus or virus-like particles, the nanoparticle construct upon in situ delivery to the subject providing a sustained release of the plant virus or virus-like particles and/or nanoparticles to the cancer cells.

### Claim 17 (depends on 16)

The method of claim 16, wherein the nanoparticles include at least one of virus or virus-like particles, dendrimers, metallic particles, inorganic particles, polymer particles, or liposomes.

### Claim 18 (depends on 16)

The method of claim 16, the nanoparticle construct comprising a plurality of dendrimers electrostatically coupled to the plant virus or virus-like particles.

### Claim 19 (depends on 16)

The method of claim 16, the nanoparticle construct having a hydrodynamic radius of about 100 nm to about two microns.

### Claim 20 (depends on 16)

The method of claim 16, the nanoparticle construct upon administration to a subject disassembling in a sustained manner at physiological pH.

### Claim 21 (depends on 16)

The method of claim 16, wherein the plant virus or virus-like particle is a plant picornavirus or a filamentous plant virus or virus-like particle.

### Claim 22 (depends on 21)

The method of claim 21, wherein the plant virus or virus-like particle is of the Secoaviridoe genus or Alphafexiviridae family.

### Claim 23 (depends on 22)

The method of claim 22, wherein the plant virus or virus-like particle is a cowpea mosaic virus-like particle or potato virus X virus-like particle.

### Claim 24 (depends on 16)

The method of claim 16, wherein the plant virus particle or virus-like particle is a rod-shaped virus particle.

### Claim 25 (depends on 24)

The method of claim 24, wherein the rod-shaped virus is a tobacco mosaic virus.

### Claim 26 (depends on 18)

The method of claim 18, wherein the dendrimer is a G3-G10 dendrimer.

### Claim 27 (depends on 16)

The method of claim 16, the nanoparticle construct comprising alternating electrostatically coupled layers of the plant virus or virus-like particles and the nanoparticles.

### Claim 28 (depends on 27)

The method of claim 27, wherein the nanoparticle comprises a plant virus or virus-like particle.

### Claim 29 (depends on 28)

The method of claim 28, wherein the plant virus or virus-like particle is loaded with or bonded to a cargo molecule.

### Claim 30 (depends on 29)

The method of claim 29, wherein the cargo molecule is an anticancer agent.

### Claim 31 (depends on 16)

The method of claim 16, wherein the nanoparticle construct is administered proximal to a tumor in the subject.

### Claim 32 (depends on 16)

The method of claim 16, wherein the cancer is metastatic cancer.

### Claim 33 (depends on 32)

The method of claim 32, wherein the cancer is selected from the group consisting of melanoma, breast cancer, colon cancer, lung cancer, and ovarian cancer.

### Claim 34 (depends on 32)

The method of claim 32, wherein the cancer is ovarian cancer.
